IQVIA’s NTB Forecast methodology revolutionizes pharmaceutical forecasting by focusing on patient acquisition, enabling accurate, nimble, and actionable forecasts. This approach enhances decision-making in investment, resource allocation, sales force sizing, promotional activities, and market access tactics, supporting brand performance from launch through its lifecycle.
Key Takeaways:
Speakers:
Ester Oben Etah
Sr. Principal, U.S. Launch Excellence, IQVIA
Brian Lasky
Sr. Principal, U.S. Launch Excellence Lead, IQVIA
Elyse Munoz
Director Thought Leadership, IQVIA